Grants and Contributions:
Title:
Delivery system development, characterization, and investigation of bone marrow delivery
Agreement Number:
1004945
Agreement Value:
$545,000.00
Agreement Date:
Apr 1, 2023 - Mar 31, 2024
Description:
This project will expand the chemistry, manufacturing and controls (CMC) workup of lead formulation materials. This will involve the development of additional quality control measures as well as the expansion of formulation testing and refinement. Additionally, this project aims to demonstrate successful gene editing in the liver.
Organization:
National Research Council Canada
Expected Results:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Location:
Vancouver, British Columbia, CA V6S 1Z3
Reference Number:
172-2023-2024-Q1-1004945
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
758555288
Recipient Type:
For-profit organization
Additional Information:
This agreement has been amended 1 time(s). The total amended value is 145,000 dollars.
Amendment Date
Nov 1, 2023
Recipient's Legal Name:
Incisive Genetics Inc.
Federal Riding Name:
Vancouver Quadra
Federal Riding Number:
59039
Program:
Industrial Research Assistance Program – Contributions to Firms
Program Purpose:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Coverage:
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.
NAICS Code:
541710
Amendments: